Verax Biomedical, Incorporated
Latest round
- Series D
Last raised
- Sep 2009
Total raised
- $20M
Investors
- 6
About Verax Biomedical, Incorporated
Verax Biomedical is focused on providing diagnostic solutions for blood product safety.54 mn in September 2019.Verax Biomedical specializes in the development and commercialization of advanced diagnostic solutions aimed at detecting bacterial contamination in blood products, particularly platelets. Their flagship product, the Platelet PGD Test, includes the PGDprime technology, designed for rapid and highly specific detection of bacterial contamination, including enhanced detection of Acinetobacter species. Their offerings primarily target hospitals, blood banks, and healthcare providers in the United States and internationally, especially in European markets where their products have received CE marking for use.Verax Biomedical's revenue model is structured around the sale of its diagnostic testing products, including the Platelet PGD Test. The company operates on a B2B basis, supplying healthcare institutions and blood banks directly with their diagnostic solutions. Transactions typically involve bulk orders of testing kits, priced according to the specifications of the products being purchased. This pricing structure accommodates the needs of large-scale healthcare providers requiring reliable and timely testing solutions for bacterial contamination in blood products. The company plans to launch new diagnostic products aimed at expanding its market offerings and enhancing its existing solutions. Specific geographic expansion plans include targeting additional European markets where access to blood safety technology is prioritized.
Who invested in Verax Biomedical, Incorporated
6 investors across 4 rounds
See all investors in Verax Biomedical, Incorporated
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Verax Biomedical, Incorporated
Who invested in Verax Biomedical, Incorporated?
Verax Biomedical, Incorporated has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Verax Biomedical, Incorporated raised?
Verax Biomedical, Incorporated has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Verax Biomedical, Incorporated last raise money?
Verax Biomedical, Incorporated's most recent round on record is a Series D, in Sep 2009.
What does Verax Biomedical, Incorporated do?
Verax Biomedical is focused on providing diagnostic solutions for blood product safety.
Where is Verax Biomedical, Incorporated headquartered?
Verax Biomedical, Incorporated is headquartered in Marlborough, US.
Which VCs invest in companies like Verax Biomedical, Incorporated?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Verax Biomedical, Incorporated's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Verax Biomedical, Incorporated? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.